EDN1 and neoplasm: A critical interplay between ET-1 axis and T cell–infiltrated phenotype that might prevent T cell homing to tumor endothelium and hinders tumor immunotherapy has been shown in ovarian cancer and in gliomas [13, 21, 22], indicating that ET-1R has the potential to significantly change the ongoing immune response in the tumour microenvironment.